Authors: Lipinski, KS Djeha, AH Ismail, T Mountain, A Young, LS Wrighton, CJ

Citation: Ks. Lipinski et al., High-level, beta-catenin/TCF-dependent transgene expression in secondary colorectal cancer tissue, MOL THER, 4(4), 2001, pp. 365-371

Authors: Djeha, AH Thomson, TA Leung, H Searle, PF Young, LS Kerr, DJ Harris, PA Mountain, A Wrighton, CJ

Citation: Ah. Djeha et al., Combined adenovirus-mediated nitroreductase gene delivery and CB1954 treatment: A well-tolerated therapy for established solid tumors, MOL THER, 3(2), 2001, pp. 233-240

Authors: Lipinski, KS Djeha, AH Krausz, E Lane, DP Searle, PF Mountain, A Wrighton, CJ

Citation: Ks. Lipinski et al., Tumour-specific therapeutic adenovirus vectors: repression of transgene expression in healthy cells by endogenous p53, GENE THER, 8(4), 2001, pp. 274-281

Authors: Djeha, AH Hulme, A Dexter, MT Mountain, A Young, LS Searle, PF Kerr, DJ Wrighton, CJ

Citation: Ah. Djeha et al., Expression of Escherichia coli B nitroreductase in established human tumorxenografts in mice results in potent antitumoral and bystander effects upon systemic administration of the prodrug CB1954, CANC GENE T, 7(5), 2000, pp. 721-731

Authors: Weedon, SJ Green, NK McNeish, IA Gilligan, MG Mautner, V Wrighton, CJ Mountain, A Young, LS Kerr, DJ Searle, PF

Citation: Sj. Weedon et al., Sensitisation of human carcinoma cells to the prodrug CB1954 by adenovirusvector-mediated expression of E-coli nitroreductase, INT J CANC, 86(6), 2000, pp. 848-854